This study investigates the link between ubiquitin‐specific peptidase 9 X‐linked (USP9X) and Alzheimer's disease (AD) pathogenesis, aiming to identify potential targets for AD diagnosis, treatment, and drug development. Here, USP9X is linked to Alzheimer disease.